164 related articles for article (PubMed ID: 30466447)
1. Antinuclear antibody and rheumatoid factor positivity in temporomandibular disorders.
Kim JR; Jo JH; Chung JW; Park JW
Head Face Med; 2018 Nov; 14(1):26. PubMed ID: 30466447
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
[TBL] [Abstract][Full Text] [Related]
3. Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders.
Gulli F; Basile U; Gragnani L; Fognani E; Napodano C; Colacicco L; Miele L; De Matthaeis N; Cattani P; Zignego AL; Rapaccini GL
Dig Liver Dis; 2016 Aug; 48(8):927-33. PubMed ID: 27289333
[TBL] [Abstract][Full Text] [Related]
4. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome.
Huo AP; Lin KC; Chou CT
Int J Rheum Dis; 2010 Feb; 13(1):39-47. PubMed ID: 20374383
[TBL] [Abstract][Full Text] [Related]
5. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course.
Hügle B; Hinze C; Lainka E; Fischer N; Haas JP
Pediatr Rheumatol Online J; 2014; 12():28. PubMed ID: 25114627
[TBL] [Abstract][Full Text] [Related]
6. Frequency of antinuclear antibodies and rheumatoid factor in healthy Turkish children.
Kasapçopur O; Ozbakir F; Arisoy N; Ingöl H; Yazici H; Ozdoğan H
Turk J Pediatr; 1999; 41(1):67-71. PubMed ID: 10770678
[TBL] [Abstract][Full Text] [Related]
7. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
8. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.
Suarez-Almazor ME; Gonzalez-Lopez L; Gamez-Nava JI; Belseck E; Kendall CJ; Davis P
J Rheumatol; 1998 Oct; 25(10):1980-5. PubMed ID: 9779854
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency and specific reactivity of serum antinuclear antibodies in patients with nonimmune chronic idiopathic neutropenia of adults.
Papadaki HA; Psyllaki M; Eliopoulos DG; Tsiroyianni A; Eliopoulos GD
Acta Haematol; 2001; 105(1):13-20. PubMed ID: 11340248
[TBL] [Abstract][Full Text] [Related]
10. Temporomandibular disorders: clinical and laboratory analyses for risk assessment of criteria for surgical therapy, a pilot study.
Halpern LR; Chase DC; Gerard DA; Behr MM; Jacobs W
Cranio; 1998 Jan; 16(1):35-43. PubMed ID: 9481984
[TBL] [Abstract][Full Text] [Related]
11. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
Bos WH; Bartelds GM; Wolbink GJ; de Koning MH; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Nurmohamed MT
J Rheumatol; 2008 Oct; 35(10):1972-7. PubMed ID: 18785316
[TBL] [Abstract][Full Text] [Related]
12. Antinuclear antibody and rheumatoid factor in silica-exposed workers.
Aminian O; Sharifian SA; Mehrdad R; Haghighi KS; Mazaheri M
Arh Hig Rada Toksikol; 2009 Jun; 60(2):185-90. PubMed ID: 19581212
[TBL] [Abstract][Full Text] [Related]
13. [Nationwide survey for autoantibodies and proposal of a new method for standardization of rheumatoid factors].
Kumagai S; Hayashi N; Ohta T; Akahoshi T; Imafuku Y; Koshiba M
Rinsho Byori; 2009 Jan; 57(1):31-41. PubMed ID: 19227188
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment.
Caramaschi P; Biasi D; Tonolli E; Pieropan S; Martinelli N; Carletto A; Volpe A; Bambara LM
Rheumatol Int; 2005 Nov; 26(1):58-62. PubMed ID: 15726373
[TBL] [Abstract][Full Text] [Related]
15. Thoracic spine manipulation did not improve maximal mouth opening in participants with temporomandibular dysfunction.
Thorp JN; Willson J
Physiother Res Int; 2020 Apr; 25(2):e1824. PubMed ID: 31729114
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States.
Sokka T; Pincus T
J Rheumatol; 2009 Jul; 36(7):1387-90. PubMed ID: 19411389
[TBL] [Abstract][Full Text] [Related]
17. Significance of antinuclear antibodies and rheumatoid factor in patients with advanced peripheral arterial disease.
Qadan LR; Ahmed AA; Abdel-Jalil S; Al-Bader MA
Med Princ Pract; 2010; 19(3):192-5. PubMed ID: 20357501
[TBL] [Abstract][Full Text] [Related]
18. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
[TBL] [Abstract][Full Text] [Related]
19. ANA+ (anti-nuclear antibody) is correlated with RF+ (rheumatoid factor) in rheumatoid arthritis.
Matsos MP; Pope JE; Spencer-Green G
Inflammopharmacology; 2004; 12(3):229-31. PubMed ID: 15527547
[No Abstract] [Full Text] [Related]
20. Young age of onset is associated with increased prevalence of circulating IgM rheumatoid factor and antinuclear antibodies at presentation in women with rheumatoid arthritis.
Jacobsen S
Clin Rheumatol; 2004 Apr; 23(2):121-2. PubMed ID: 15045625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
